Wen‐Lung Ma

2.5k total citations
68 papers, 1.9k citations indexed

About

Wen‐Lung Ma is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Wen‐Lung Ma has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Surgery and 15 papers in Cancer Research. Recurrent topics in Wen‐Lung Ma's work include Estrogen and related hormone effects (11 papers), Prostate Cancer Treatment and Research (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Wen‐Lung Ma is often cited by papers focused on Estrogen and related hormone effects (11 papers), Prostate Cancer Treatment and Research (9 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Wen‐Lung Ma collaborates with scholars based in Taiwan, United States and China. Wen‐Lung Ma's co-authors include Chawnshang Chang, Shuyuan Yeh, Yao‐Ching Hung, Cheng–Lung Hsu, Wei‐Chun Chang, Wei‐Chung Cheng, Long‐Bin Jeng, Xiujun Cai, Lumin Chen and Yuh-Ling Chen and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Wen‐Lung Ma

67 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Lung Ma Taiwan 23 839 480 458 326 277 68 1.9k
Aijuan Qu China 32 1.3k 1.6× 596 1.2× 180 0.4× 252 0.8× 662 2.4× 66 2.9k
Chunyan Gu China 24 1.5k 1.8× 678 1.4× 276 0.6× 295 0.9× 133 0.5× 93 2.3k
Yeon‐Kyung Choi South Korea 23 1.1k 1.3× 662 1.4× 184 0.4× 257 0.8× 414 1.5× 57 2.3k
Yuliang Wang China 24 599 0.7× 264 0.6× 320 0.7× 299 0.9× 199 0.7× 100 1.6k
Bostjan Humar Switzerland 34 1.3k 1.5× 433 0.9× 395 0.9× 576 1.8× 565 2.0× 74 3.0k
Wook Jin South Korea 25 721 0.9× 358 0.7× 334 0.7× 504 1.5× 225 0.8× 55 1.8k
Junhui Zhen China 23 807 1.0× 273 0.6× 172 0.4× 138 0.4× 290 1.0× 54 2.0k
Guizhi Yang China 16 907 1.1× 259 0.5× 172 0.4× 261 0.8× 292 1.1× 29 1.6k
Chew-Wun Wu Taiwan 25 879 1.0× 494 1.0× 541 1.2× 501 1.5× 320 1.2× 87 2.4k
Yaxi Chen China 18 867 1.0× 544 1.1× 145 0.3× 184 0.6× 565 2.0× 50 1.9k

Countries citing papers authored by Wen‐Lung Ma

Since Specialization
Citations

This map shows the geographic impact of Wen‐Lung Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Lung Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Lung Ma more than expected).

Fields of papers citing papers by Wen‐Lung Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Lung Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Lung Ma. The network helps show where Wen‐Lung Ma may publish in the future.

Co-authorship network of co-authors of Wen‐Lung Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Lung Ma. A scholar is included among the top collaborators of Wen‐Lung Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Lung Ma. Wen‐Lung Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Yu‐Ting, Wei‐Chun Chang, Lumin Chen, et al.. (2024). Ether‐Linked Glycerophospholipids Are Potential Chemo‐Desensitisers and Are Associated With Overall Survival in Carcinoma Patients. Journal of Cellular and Molecular Medicine. 28(24). e70277–e70277. 1 indexed citations
2.
Abbas, Sk Jahir, Nayim Sepay, Fangfang Xia, et al.. (2024). Target Bioconjugation of Protein Through Chemical, Molecular Dynamics, and Artificial Intelligence Approaches. Metabolites. 14(12). 668–668. 1 indexed citations
3.
Lee, Hsiang‐Chun, et al.. (2023). Association of lipid composition and unsaturated fatty acids of VLDL with atrial remodeling in metabolic syndrome. Scientific Reports. 13(1). 6575–6575. 7 indexed citations
4.
Wu, Yu-Chun, Huihua Yang, Ting‐Yuan Tu, et al.. (2022). A Novel 3D Culture Scaffold to Shorten Development Time for Multicellular Tumor Spheroids. International Journal of Molecular Sciences. 23(22). 13962–13962. 2 indexed citations
5.
Huang, Chieh-Liang, Yao‐Chang Chiang, Juan‐Cheng Yang, et al.. (2021). Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment. Frontiers in Endocrinology. 12. 638884–638884. 1 indexed citations
6.
Chang, Wei‐Chun, et al.. (2020). Early Exposure to Gut Microbiome Reduces Hepatocellular Carcinoma Risks in Mice. BioMed Research International. 2020(1). 1 indexed citations
7.
Chen, Lumin, Wen‐Lung Ma, Wei‐Chung Cheng, et al.. (2020). Targeting lipid droplet lysophosphatidylcholine for cisplatin chemotherapy. Journal of Cellular and Molecular Medicine. 24(13). 7187–7200. 11 indexed citations
8.
Lai, Hsueh‐Chou, Yu-Ting Su, Chun-Chieh Yeh, et al.. (2020). Androgen Receptor Enhances the Efficacy of Sorafenib Against Hepatocellular Carcinoma Through Enriched EpCAM Stemness. Anticancer Research. 40(3). 1285–1295. 5 indexed citations
9.
Yeh, Chun‐Chieh, Sudhir Pandey, Hsueh‐Chou Lai, et al.. (2020). Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models. Frontiers in Oncology. 10. 572861–572861. 5 indexed citations
10.
Lai, Hsueh‐Chou, et al.. (2018). Impact of age at appendectomy on development of type 2 diabetes: A population-based cohort study. PLoS ONE. 13(10). e0205502–e0205502. 5 indexed citations
11.
Shi, Liang, Hui Lin, Gonghui Li, et al.. (2016). Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression. Molecular Cancer Therapeutics. 15(4). 731–742. 46 indexed citations
12.
Chen, Yung‐Hsiang, Chao‐Jung Chen, Yang‐Chang Wu, et al.. (2015). Proteomic analysis of urethral protein expression in an estrogen receptor α-deficient murine model of stress urinary incontinence. World Journal of Urology. 33(10). 1635–1643. 6 indexed citations
13.
14.
Chen, Yung‐Hsiang, Chao‐Jung Chen, Shuyuan Yeh, et al.. (2014). Urethral Dysfunction in Female Mice with Estrogen Receptor β Deficiency. PLoS ONE. 9(10). e109058–e109058. 6 indexed citations
15.
16.
17.
Yasmin‐Karim, Sayeda, Michael R. King, Deanne Mickelsen, et al.. (2011). Suppression of Prostate Cancer Cell Rolling and Adhesion to Endothelium by 1α,25-Dihydroxyvitamin D3. American Journal Of Pathology. 178(2). 872–880. 47 indexed citations
18.
Lin, Hung‐Yun, I‐Chen Yu, Yei‐Tsung Chen, et al.. (2008). Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology. 47(6). 1924–1935. 163 indexed citations
19.
Kim, Eungseok, et al.. (2007). TR4 orphan nuclear receptor functions as an apoptosis modulator via regulation of Bcl-2 gene expression. Biochemical and Biophysical Research Communications. 361(2). 323–328. 18 indexed citations
20.
Kang, Hong‐Yo, Ko-En Huang, Shiuh Young Chang, et al.. (2002). Differential Modulation of Androgen Receptor-mediated Transactivation by Smad3 and Tumor Suppressor Smad4. Journal of Biological Chemistry. 277(46). 43749–43756. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aijuan Qu Breakdown of academic impact, for papers by Chunyan Gu Breakdown of academic impact, for papers by Yeon‐Kyung Choi Breakdown of academic impact, for papers by Yuliang Wang Breakdown of academic impact, for papers by Bostjan Humar Breakdown of academic impact, for papers by Wook Jin Breakdown of academic impact, for papers by Junhui Zhen Breakdown of academic impact, for papers by Guizhi Yang Breakdown of academic impact, for papers by Chew-Wun Wu Breakdown of academic impact, for papers by Yaxi Chen
Rankless by CCL
2026